AnalystsAndres Maldonado
Andres Maldonado's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Top 8%
#412 out of 5206 analysts
Average Return
+26.8%
Win Rate
42%39 out of 92
Risk vs Reward
Poor
Good

Andres Maldonado's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Erasca IncERAS
+835.62%$1.46$13.66
2025-04-30 -
2026-02-27
Buy
Erasca IncERAS
+792.81%$1.53$13.66
2025-03-21 -
2026-02-27
Buy
Scholar Rock Holding CorpSRRK
+314.00%$8.07$33.41
2024-06-25 -
2025-06-24
Buy
Scholar Rock Holding CorpSRRK
+228.91%$8.06$26.51
2023-10-12 -
2024-10-11
Buy
Scholar Rock Holding CorpSRRK
+215.71%$9.80$30.94
2024-06-04 -
2025-06-03
Buy

Andres Maldonado Analyst Color

Get additional color on Andres Maldonado's coverage of popular stocks

Andres Maldonado's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Novabridge BiosciencesNBP
1Buy$7.00+113.41%Reiterates
8 months ago
Aura Biosciences IncAURA
1Buy$22.00+273.51%Assumes
9 months ago
Zentalis Pharmaceuticals IncZNTL
1Buy$10.00+318.41%Reiterates
10 months ago
Corbus Pharmaceuticals Holdings IncCRBP
2Buy$40.00+366.74%Maintains
10 months ago
Tscan Therapeutics IncTCRX
1Buy$10.00+843.40%Maintains
10 months ago
Erasca IncERAS
10Buy$6.00-56.08%Reiterates
10 months ago
Foghorn Therapeutics IncFHTX
1Buy$13.00+128.87%Reiterates
10 months ago
Sutro Biopharma IncSTRO
1Hold$20.00-2.30%Reiterates
10 months ago
Protara Therapeutics IncTARA
1Buy$23.00+261.64%Reiterates
10 months ago
Cg Oncology IncCGON
13Buy$75.00+27.55%Reiterates
10 months ago
Day One Biopharmaceuticals IncDAWN
14Buy$36.00+239.62%Reiterates
a year ago
Mural Oncology PLCMURA
5Buy$6.00+194.12%Maintains
a year ago
Werewolf Therapeutics IncHOWL
16Buy$15.00+2,400.00%Reiterates
a year ago
Engene Holdings IncENGN
2Buy$25.00+147.28%Reiterates
a year ago
Scholar Rock Holding CorpSRRK
13Buy$50.00N/AMaintains
a year ago
Imagenebio IncIMA
11Buy$48.00N/AReiterates
a year ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.